We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Orthopedics Centre of Excellence Planned for Guy’s Hospital

By HospiMedica International staff writers
Posted on 11 Dec 2017
Print article
Image: Guy\'s and St. Thomas\' hospital and Johnson & Johnson join forces to improve orthopedic care (Photo courtesy of Guy’s and St. Thomas’ NHS Foundation Trust).
Image: Guy\'s and St. Thomas\' hospital and Johnson & Johnson join forces to improve orthopedic care (Photo courtesy of Guy’s and St. Thomas’ NHS Foundation Trust).
Johnson & Johnson (JNJ; New Brunswick, NJ, USA) Managed Services and Guy's and St. Thomas' NHS Foundation Trust (London, United Kingdom) have entered into a 15-year partnership to deliver an Orthopedics Centre of Excellence.

The new partnership between JNJ Managed Services and Guy’s and St. Thomas’ NHS Foundation Trust is designed to optimize the standard of care for orthopedic patients by addressing challenges facing the NHS highlighted in two recent reports by Lord Carter and Professor Briggs, which attempt to address increasing resource challenges in the United Kingdom, partly due to changing demographics that project that by 2030, there will be around 15 million people in the United Kingdom over the age of 65.

As part of the agreement, the orthopedics center at Guy’s Hospital will be expanded and redeveloped, allowing more patients to have access to services. Plans include the development of an additional operating theatre in year one, and eight new state-of-the-art theatres by the end of year three. JNJ will also streamline the supply chain to procure devices, surgical instruments, and implants needed for orthopedic surgery. The Center of Excellence will also provide a hub for education and training, and offer a dedicated space to facilitate leading-edge research.

“The Johnson & Johnson Managed Services partnership will further increase the time that frontline clinicians can focus on patient care and enable us to identify opportunities to improve the supply chain,” said Peter Earnshaw, clinical director of surgery at Guy’s and St. Thomas’. “Through the development of new operating theatres, it will also increase capacity so that we can treat more patients more quickly and will give our clinical teams opportunities to be at the forefront of new developments in orthopedic care.”

“This latest collaboration is testament to our ongoing commitment to Guy’s and St. Thomas’ NHS Foundation Trust, and our commitment to join forces with health care systems to help them address their most pressing challenges,” said Michelle Brennan, Company Group Chair of JNJ Medical Devices Europe, Middle East, and Africa.

Related Links:
Johnson & Johnson
Guy's and St. Thomas' NHS Foundation Trust
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Portable Patient Lift
Maxi Move
New
Digital Radiography System
DigiEye 680

Print article

Channels

Critical Care

view channel
Image: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants (Photo courtesy of 123RF)

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. Locally advanced tumors, in particular, present challenges for surgical treatment.... Read more

Surgical Techniques

view channel
Image: LumiSystem is the combination of two FDA approved products: LUMISIGHT (pegulicianine) and Lumicell Direct Visualization System (Photo courtesy of Lumicell)

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Breast cancer is the most frequently diagnosed cancer in women, with lumpectomies being the most common treatment approach. About 65% of women diagnosed with breast cancer undergo a lumpectomy, also referred... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.